Nephrotic Syndrome Induced by Lenvatinib Treatment for Hepatocellular Carcinoma

Figure 1

Abdominal computed tomography revealing a cirrhotic liver with 3 partial lipiodol-staining masses at left hepatic lobe with remaining viable part, size 3.7 × 2.9 cm at segment III (viable part at anteroinferior aspect), 4.5 × 4.4 cm at segment IVb (viable part at right posterolateral aspect), and 2.7 × 2.5 cm at segment II (small viable part at posterior aspect) in axial and coronal view of arterial phase (a-b) and axial and coronal view of portovenous phase (c-d), respectively.

(a)

(b)

(c)

(d)